DA
Healthcare & Life Sciences
Delenex Therapeutics AG
Switzerland
Delenex Therapeutics AG is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series A, 1 tracked investor.
series-a
series-a
Stage
1
Investors
About Delenex Therapeutics AG
Delenex Therapeutics AG is a company headquartered in Switzerland. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Delenex Therapeutics AG is a clinical-stage biopharmaceutical company that develops antibody therapeutics using its proprietary PENTBody platform to create potent and stable antibody fragments targeting diseases including oncology, Crohn's disease, and psoriasis.
Explore Delenex Therapeutics AG's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.